Risk factor and prediction model development for severe radiation-induced oral mucositis in head and neck tumors
- PMID: 39105623
- PMCID: PMC11520562
- DOI: 10.1080/14796694.2024.2384353
Risk factor and prediction model development for severe radiation-induced oral mucositis in head and neck tumors
Abstract
Aim: This article aims to identify risk factors for severe radiation-induced oral mucositis (RIOM) in head and neck cancer (HNC) patients. In addition, we intend to establish a predictive model in patients undergoing intensity-modulated radiotherapy.Patients & methods: In this retrospective study, several HNC patients (n = 179) treated at Zhejiang Provincial People's Hospital from January 2019 to June 2023 were considered. The recruited subjects were divided into modeling and validation groups. The experimental data on clinical characteristics and treatment were collected and analyzed to identify predictive factors for severe RIOM based on the logistic regression approach.Results: The results indicated that severe RIOM occurred in 55.3% of patients. Accordingly, significant predictors included smoking history, diabetes, concurrent chemotherapy, cumulative radiation dose and weight loss of ≥5% in relative to admission weight. A nomogram based on these factors was validated, showing excellent predictive accuracy.Conclusion: In summary, the predictive model could effectively identify high-risk patients for severe RIOM, enabling the design of targeted interventions and improving patient management during radiotherapy.
Keywords: head and neck tumors; nomogram; oral mucosa; radiation therapy.
Plain language summary
[Box: see text].
Conflict of interest statement
The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Figures




References
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660 - DOI - PubMed
-
• This comprehensive review provides crucial global cancer statistics essential for understanding the epidemiological context of head and neck cancers.
-
- Rabinovitch R, Grant B, Berkey BA, et al. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90–03. Head Neck. 2006;28(4):287–296. doi: 10.1002/hed.20335 - DOI - PubMed
-
• This study offers insights into the role of nutrition support in improving outcomes during radiotherapy for head and neck cancers.
-
- Jie L, Shimiao D, Hao J, et al. Analysis of positioning error of helical tomographic radiotherapy for head and neck tumors. Modern Med J China. 2021;23(6):53–55.
-
- De Ruysscher D, Niedermann G, Burnet NG, et al. Radiotherapy toxicity. Nat Rev Dis Primers. 2019;5(1):13. doi: 10.1038/s41572-019-0064-5 - DOI - PubMed
-
• This review discusses various aspects of radiotherapy-induced toxicities, including oral mucositis, relevant to treatment planning and patient management.
-
- Kechen D, Meng Z, Lin X, et al. Analysis of risk factors for severe oral mucositis induced by intensity-modulated radiotherapy for nasopharyngeal carcinoma. World J Integrated Traditional Western Med. 2021;16(10):1924–1928.
-
• This study identifies specific risk factors contributing to severe oral mucositis during intensity-modulated radiotherapy, which is crucial for treatment optimization.